BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30088191)

  • 1. Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus.
    Palmer JD; Bhamidipati D; Mehta M; Williams NL; Dicker AP; Werner-Wasik M; Shi W
    J Neurooncol; 2018 Nov; 140(2):421-426. PubMed ID: 30088191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma in the elderly - How do we choose who to treat?
    Lorimer CF; Saran F; Chalmers AJ; Brock J
    J Geriatr Oncol; 2016 Nov; 7(6):453-456. PubMed ID: 27478132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
    Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
    J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.
    Minniti G; Scaringi C; Lanzetta G; Terrenato I; Esposito V; Arcella A; Pace A; Giangaspero F; Bozzao A; Enrici RM
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):109-15. PubMed ID: 25442339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma in the elderly: initial management.
    de Moraes FY; Laperriere N
    Chin Clin Oncol; 2017 Aug; 6(4):39. PubMed ID: 28841801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.
    Franceschi E; Depenni R; Paccapelo A; Ermani M; Faedi M; Sturiale C; Michiara M; Servadei F; Pavesi G; Urbini B; Pisanello A; Crisi G; Cavallo MA; Dazzi C; Biasini C; Bertolini F; Mucciarini C; Pasini G; Baruzzi A; Brandes AA;
    J Neurooncol; 2016 May; 128(1):157-162. PubMed ID: 26943851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.
    Abhinav K; Aquilina K; Gbejuade H; La M; Hopkins K; Iyer V
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1375-8. PubMed ID: 23333005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MGMT inactivation and clinical response in newly diagnosed GBM patients treated with Gliadel.
    Grossman R; Burger P; Soudry E; Tyler B; Chaichana KL; Weingart J; Olivi A; Gallia GL; Sidransky D; Quiñones-Hinojosa A; Ye X; Brem H
    J Clin Neurosci; 2015 Dec; 22(12):1938-42. PubMed ID: 26249244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
    Gállego Pérez-Larraya J; Ducray F; Chinot O; Catry-Thomas I; Taillandier L; Guillamo JS; Campello C; Monjour A; Cartalat-Carel S; Barrie M; Huchet A; Beauchesne P; Matta M; Mokhtari K; Tanguy ML; Honnorat J; Delattre JY
    J Clin Oncol; 2011 Aug; 29(22):3050-5. PubMed ID: 21709196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.
    Hundsberger T; Hottinger AF; Roelcke U; Roth P; Migliorini D; Dietrich PY; Conen K; Pesce G; Hermann E; Pica A; Gross MW; Brügge D; Plasswilm L; Weller M; Putora PM
    J Neurooncol; 2016 Jan; 126(1):175-183. PubMed ID: 26459327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.
    Brandes AA; Tosoni A; Franceschi E; Sotti G; Frezza G; Amistà P; Morandi L; Spagnolli F; Ermani M
    J Clin Oncol; 2009 Mar; 27(8):1275-9. PubMed ID: 19188675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
    Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
    Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
    J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
    J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma.
    Mendez JS; Govindan A; Leong J; Gao F; Huang J; Campian JL
    J Neurooncol; 2016 Apr; 127(2):329-35. PubMed ID: 26725885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of newly diagnosed malignant glioma in the elderly people: new trials that impact therapy.
    Chamberlain MC
    Int J Clin Pract; 2013 Dec; 67(12):1225-7. PubMed ID: 24246204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Elderly Patients with Glioblastoma.
    Roth P; Gramatzki D; Weller M
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):35. PubMed ID: 28324304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.